On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

A. O. Ordine Mauriziano di Torino

InstitutionResearch output, impact & collaborations

A. O. Ordine Mauriziano di Torino is a institution indexed in ScholarIQ from OpenAlex.

What is known about A. O. Ordine Mauriziano di Torino?

ScholarIQrecord summary

A. O. Ordine Mauriziano di Torino is a research organisation in Turin, IT. OpenAlex records 3,760 works and 236,842 citations for it. 965 researchers list it as their most recent affiliation.

How many works does A. O. Ordine Mauriziano di Torino have?

ScholarIQindexed works

A. O. Ordine Mauriziano di Torino has 3,760 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does A. O. Ordine Mauriziano di Torino have?

ScholarIQcitation count

A. O. Ordine Mauriziano di Torino has 236,842 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at A. O. Ordine Mauriziano di Torino?

ScholarIQresearcher count

A. O. Ordine Mauriziano di Torino has 965 researchers in the ScholarIQ index.

What is the average h-index at A. O. Ordine Mauriziano di Torino?

ScholarIQavg h-index

A. O. Ordine Mauriziano di Torino has an average h-index of 73 in OpenAlex.

What is the ROR of A. O. Ordine Mauriziano di Torino?

ScholarIQror

The ROR for A. O. Ordine Mauriziano di Torino is on the source record.

What is the OpenAlex record for A. O. Ordine Mauriziano di Torino?

ScholarIQopenalex

The OpenAlex for A. O. Ordine Mauriziano di Torino is on the source record.

Who are the most-cited researchers behind A. O. Ordine Mauriziano di Torino?

ScholarIQtop researchers by citations
1
Annamaria Iagnocco · Rheumatoid Arthritis Research and Therapies
528 works22,283 citations
2
Elena Conti · RNA Research and Splicing
357 works17,569 citations

What are the most-cited papers on A. O. Ordine Mauriziano di Torino?

ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher J Edwards, Kimme L Hyrich, Janet Pope, Savia de Souza, Tanja Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin Winthrop, Alejandro Balsa, Joan M. Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Myrna Cardiel, Katerina Chatzidionysiou, Cătălin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques‐Eric Gottenberg, Espen A. Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde
Annals of the Rheumatic Diseases. 20221,851 CitationsOPEN ACCESS
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Bhaskar Dasgupta, Marco A. Cimmino, Hilal Maradit Kremers, Wolfgang Schmidt, Michael Schirmer, Carlo Salvarani, Artur Bachta, Christian Dejaco, Christina Duftner, Hanne Jensen, P. Duhaut, Gyula Poór, Novák Pál Kaposi, Péter Mandl, Péter Bálint, Zsuzsa Schmidt, Annamaria Iagnocco, Carlotta Nannini, Fabrizio Cantini, Pierluigi Macchioni, Nicolò Pipitone, Montserrat Del Amo, Georgina Espígol‐Frigolé, María C. Cid, Víctor M. Martínez‐Taboada, Elisabeth Nordborg, Haner Di̇reskeneli̇, Sibel Zehra Aydın, Khalid Ahmed, B L Hazleman, Barbara Silverman, Colin Pease, Richard J. Wakefield, Raashid Luqmani, Andy Abril, Clement J. Michet, Ralph Marcus, Neil Gonter, Mehrdad Maz, Rickey E. Carter, Cynthia S. Crowson, Eric L. Matteson
Annals of the Rheumatic Diseases. 2012663 CitationsOPEN ACCESS

How much of the research on A. O. Ordine Mauriziano di Torino is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
0%
Bronze
50%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial